Back

GLUCO-TAVI trial: treatment with glucocorticoids in patients undergoing TAVI to reduce the incidence of atrioventricular block and pacemaker implantation

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Transcatheter aortic valve implantation Aortic Valve Intervention ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Laura Fuertes Kenneally

General University Hospital of Alicante, Alicante (Spain)

2 More presentations in this session

Presentation thumbnail
State-of-the-art lecture on transcatheter aortic valve implantation
Professor S. Windecker (Bern, CH)
Slides Video
Presentation thumbnail
Sex-based differences in outcomes of transcatheter aortic valve replacement: a meta-analysis and meta-regression of 657,850 patients
Doctor M. Benhammou (Oran, DZ) Doctor A. Haidarah (Chengdu, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Transcatheter aortic valve implantation
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Session
Transcatheter aortic valve implantation
thumbnail
Congress Presentation
The impact of mitigating perioperative inflammation on risk of conduction disturbances after transcatheter aortic valve implantation; is it time to coat the valve?
thumbnail
Congress Presentation
Comparison of patients developing early versus delayed indication for permanent pacemaker implantation after transcatheter aortic valve implantation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources